Antigenic differences between the <scp>EG</scp>95‐related proteins from <i><scp>E</scp>chinococcus granulosus </i><scp>G</scp>1 and <scp>G</scp>6 genotypes<i>:</i> implications for vaccination

Abstract excerpt

Cystic echinococcosis caused by Echinococcus granulosus remains an important and neglected issue in public health. The study of the likely efficacy of the currently available EG95 vaccine against other genotypes of the parasite is important to improve the vaccine as a potential tool to be used in control programmes. The recombinant vaccine EG95-1G1 was developed based on the G1 genotype of E. granulosus....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immunotherapy and Immune Responses
• Share to Parasitic Infections and Diagnostics
• Share to Parasitic infections in humans and animals